Surgical resection improves survival for gastric cancer liver metastases

A population-based analysis of 3,694 gastric cancer patients with liver metastases revealed that those undergoing cancer-directed surgery experienced significantly longer median overall survival, 12 months versus 6 months for non-resection patients. After adjusting for selection bias, Cox regression indicated a substantial survival benefit, with a hazard ratio of 0.562. These findings highlight the importance of surgical resection in this challenging condition, although identifying optimal candidates for surgery remains a critical area for further research.